Computational design of scFv anti-receptor binding domain of SARS-CoV-2 spike protein based on antibody S230 anti-SARS-CoV-1-Reference-Cited by-同舟云学术

Computational design of scFv anti-receptor binding domain of SARS-CoV-2 spike protein based on antibody S230 anti-SARS-CoV-1

Published:2023-10-25 Issue:1 Volume:42 Page:22-33
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Firdaus Ade R. R.¹²^ORCID,Baroroh Umi¹³^ORCID,Ramdani Tohari Taufik¹,Hardianto Ari¹⁴,Subroto Toto¹⁴,Yusuf Muhammad¹⁴^ORCID

Affiliation:

1. Research Center for Molecular Biotechnology and Bioinformatics, Universitas Padjadjaran, Bandung, Indonesia

2. Biotechnology Master Program, Postgraduate School, Universitas Padjadjaran, Bandung, Indonesia

3. Department of Pharmacy, Sekolah Tinggi Farmasi Indonesia, Bandung, Indonesia

4. Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, Indonesia

Funder

Ministry of Education, Culture, Research, and Technology, Republic of Indonesia

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2265485

Reference38 articles.

1. scFv Antibody: Principles and Clinical Application

2. Case D. A. Betz R. M. Cerutti D. S. Cheatham III T. E. Darden T. A. Duke R. E. Giese T. J. Gohlke H. Goetz A. W. Homeyer N. Izadi S. Janowski P. Kaus J. Kovalenko A. Lee T. S. LeGrand S. Li P. Lin C. Luchko T. Luo R. Madej B. Mermelstein D. Merz K. M. Monard G. Nguyen H. Nguyen H. T. Omelyan I. Onufriev A. Roe D. R. Roitberg A. Sagui C. Simmerling C. L. Botello-Smith W. M. Swails J. Walker R. C. Wang J. Wolf R. M. Wu X. Xiao L. & Kollman P. A. (2016). Amber 2016 . San Francisco: University of California.

3. Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein–protein binding free energies and re-rank binding poses generated by protein–protein docking

4. Tackling COVID-19 with neutralizing monoclonal antibodies

5. Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing